Skip to main content

Viemed Healthcare, Inc.

corporate_fare Company Profile

Viemed Healthcare, Inc.

VMD·NASDAQ·Industrial Applications And Services·CIK 0001729149

Viemed Healthcare, Inc. provides home medical equipment (HME) and post-acute healthcare services across the United States, specializing in respiratory, chronic care, and women's health products and services. The company focuses on delivering in-home treatment, with clinical practitioners providing therapy and counseling to patients using technology. Viemed aims to grow by increasing the number of patients served and the level of care provided through its technology-enabled, home-based clinical care and chronic disease management model. Its care programs are designed to treat patients at home for less total cost and with superior quality of care. Viemed's services include respiratory disease management, which involves renting various HME devices, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, and the sale of associated supplies. The company also offers women's health products and services, and healthcare staffing services. Viemed serves patients in all 50 states of the United States. As of December 31, 2025, the company employed 401 licensed respiratory therapists (RTs), who represented approximately 29% of its total employee count. Beyond its internal needs, Viemed also provides healthcare staffing and recruitment services to external healthcare institutions. The company seeks to expand its existing service areas and enter new territories by focusing overhead costs on personnel rather than physical location costs.

Viemed Healthcare, Inc. (NASDAQ:VMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for VMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for VMD spans 10-Q, 8-K, DEF 14A, 4.

Recent high-impact activity:

  • Viemed 10-Q Details Record Q3: $80.7M Revenue, $4.6M Net Income, $9.7M Cash
  • Viemed Posts Record $80.7M Q3 Revenue, Lifts Low End of 2026 Guidance
  • Viemed Q3 Revenue Hits $80.7M, Net Income $4.7M
  • Viemed Reaffirms 2026 Guidance and Authorizes New 5% Buyback
  • Viemed Q2 Revenue Hits Record $78.1M, Raises Low End of 2026 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$270.28M
Net Income
$14.93M
Diluted EPS
$0.37
Op. Cash Flow
$51.92M
Free Cash Flow
$11.93M
Gross Profit
$155.46M
Operating Income
$22.95M
Cash & Equivalents
$13.5M
Total Debt
$12.38M
Debt / Equity
0.09×
Net Margin
5.5%
Shares Outstanding
38.02M sh
Source: 10-K · filed 2026-03-04 · accession 0001729149-26-000009

Short Interest & Short Volume

8.51 days to cover

FINRA reported short interest of 1,509,311 shares in VMD as of the October 30, 2026 settlement, a 1.7% decrease from the prior period — about 8.5 days to cover at its recent average daily volume. On November 19, 2026, 32.4% of VMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,509,311 shares as of October 30, 2026
Change vs prior period▼ 1.7%
Days to cover8.51 at avg daily volume of 177,313
Daily short volume (FINRA facilities)32.4% of 56,978 shares on November 19, 2026
5-day average short volume27.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with V →
$8.52 -1.05% today
52-week range · as of 2026-11-04 $6.05 – $12.61
Market cap
$322.85M
Volume
182.4K (0.9× avg)
3-mo avg 205.4K
Live data · 2026-11-20 20:41 UTC · Market open

show_chartPrice Chart

Loading chart...

feed VMD - Latest Insights

VMD
Nov 04, 2026, 5:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.05
Real-time Price: $8.52 info
Change: -$1.53 (-15%) info
Market Cap: $322.849M info
VMD
Nov 04, 2026, 5:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.05
Real-time Price: $8.52 info
Change: -$1.53 (-15%) info
Market Cap: $322.849M info
VMD
Nov 04, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $10.05
Real-time Price: $8.52 info
Change: -$1.53 (-15%) info
Market Cap: $322.849M info
VMD
Aug 20, 2026, 5:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.57
Real-time Price: $8.52 info
Change: -$0.050 (-0.58%) info
Market Cap: $322.849M info
VMD
Aug 03, 2026, 5:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $8.52 info
Change: -$2.48 (-23%) info
Market Cap: $322.849M info
VMD
Aug 03, 2026, 5:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $8.52 info
Change: -$2.48 (-23%) info
Market Cap: $322.849M info
VMD
Aug 03, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $8.52 info
Change: -$2.48 (-23%) info
Market Cap: $322.849M info
VMD
Jun 04, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.84
Real-time Price: $8.52 info
Change: -$1.32 (-13%) info
Market Cap: $322.849M info
VMD
May 05, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.50
Real-time Price: $8.52 info
Change: -$0.980 (-10%) info
Market Cap: $322.849M info
VMD
May 05, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $9.62
Real-time Price: $8.52 info
Change: -$1.10 (-11%) info
Market Cap: $322.849M info
VMD
Apr 22, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $9.51
Real-time Price: $8.52 info
Change: -$0.990 (-10%) info
Market Cap: $322.849M info
VMD
Mar 20, 2026, 5:06 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $8.63
Real-time Price: $8.52 info
Change: -$0.110 (-1%) info
Market Cap: $322.849M info
VMD
Mar 20, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $8.63
Real-time Price: $8.52 info
Change: -$0.110 (-1%) info
Market Cap: $322.849M info
VMD
Mar 19, 2026, 4:11 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $9.22
Real-time Price: $8.52 info
Change: -$0.700 (-8%) info
Market Cap: $322.849M info
VMD
Mar 16, 2026, 4:51 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.97
Real-time Price: $8.52 info
Change: -$1.45 (-15%) info
Market Cap: $322.849M info
VMD
Mar 04, 2026, 4:50 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $8.95
Real-time Price: $8.52 info
Change: -$0.430 (-5%) info
Market Cap: $322.849M info
VMD
Mar 04, 2026, 4:45 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $9.08
Real-time Price: $8.52 info
Change: -$0.560 (-6%) info
Market Cap: $322.849M info
VMD
Feb 02, 2026, 5:35 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $8.00
Real-time Price: $8.52 info
Change: +$0.520 (+6%) info
Market Cap: $322.849M info
VMD
Feb 02, 2026, 5:35 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $8.00
Real-time Price: $8.52 info
Change: +$0.520 (+6%) info
Market Cap: $322.849M info
VMD
Feb 02, 2026, 5:34 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $8.00
Real-time Price: $8.52 info
Change: +$0.520 (+6%) info
Market Cap: $322.849M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets